Premenstrual syndrome. Premenstrual tension syndrome
Conditions
Interventions
Intervention 1: Intervention group 1: This group receives tDCS with an electric current of 2 mA for 20 minutes in the dorsolateral prefrontal cortex (DLPFC) for 10 sessions (10 consecutive days) durin
Sponsors
Shahed University
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Women between the ages of 18 and 45 who have had more than two periods with symptoms of premenstrual syndrome Having regular menstruation
Exclusion criteria
Exclusion criteria: at the moment , taking medication for premenstrual syndrome Prosthesis in the skull area History of brain tumor History of seizures Battery in the heart Clinical disorders such as Major Depression Disorder, Bipolar Disorder, Generalized Anxiety Disorder, Acute Stress Disorder, and Post-Traumatic Stress Disorder Personality Disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Emotion regulation score, based on the Difficulties in Emotion Regulation Scale – 16 items(DERS-16). Timepoint: Before starting interventions once in the follicular phase In the luteal phase, once in the first session before the start of the intervention; at the end of the fifth session of the intervention; at the end of the tenth session of the intervention; After the intervention is completed, once in the follicular phase and once in the luteal phase. Method of measurement: Difficulties in Emotion Regulation Scale – 16 items(DERS-16) Bjureberg.;Mood symptom score based on the Depression Anxiety Stress Scales - 21(DASS-21). Timepoint: Before starting interventions once in the follicular phase In the luteal phase, once in the first session before the start of the intervention; at the end of the fifth session of the intervention; at the end of the tenth session of the intervention; After the intervention is completed, once in the follicular phase and once in the luteal phase. Method of measurement: Depression Anxiety Stress Scales - 21(DASS-21) Lovibond.;Cognitive performance score in attention and response inhibition by the Integrated Visual and Auditory Continuous Performance Test(IVA-2). Timepoint: Before starting interventions once in the follicular phase In the luteal phase, once in the first session before the start of the intervention; at the end of the fifth session of the intervention; at the end of the tenth session of the intervention; After the intervention is completed, once in the follicular phase and once in the luteal phase. Method of measurement: Integrated Visual and Auditory Continuous Performance Test(IVA-2). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Tavana
Shahed University
Outcome results
None listed